Guardant Health, Inc. SEC filings GH

Guardant Health, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jun 5, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Guardant Health, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Nov 3, 2026 Nov 2, 2026
8-K Current report
Officer or director change
Nov 3, 2026 Nov 2, 2026
S-3ASR Automatic shelf registration Jul 30, 2026 —
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 17, 2026
8-K Current report
Officer or director change
Apr 27, 2026 Apr 27, 2026
S-8 Employee stock plan registration Feb 20, 2026 —
10-K Annual report Feb 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 11, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 7, 2025 Nov 4, 2025
424B5 Prospectus supplement Nov 6, 2025 —
FWP Free writing prospectus Nov 5, 2025 —
FWP Free writing prospectus Nov 4, 2025 —
424B5 Prospectus supplement Nov 4, 2025 —
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Regulation FD disclosure
Sep 24, 2025 Sep 24, 2025
8-K Current report
Officer or director change
Sep 15, 2025 Sep 12, 2025
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
8-K Current report
Shareholder vote results
Jun 20, 2025 Jun 18, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 18, 2025
8-K Current report
Material agreement, New debt
Apr 9, 2025 Apr 3, 2025
S-8 Employee stock plan registration Feb 24, 2025 —
10-K Annual report Feb 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 20, 2025 Feb 20, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Feb 14, 2025 Feb 14, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 7, 2025 Feb 6, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Officer or director change
Oct 24, 2024 Oct 21, 2024
8-K Current report
Material agreement
Aug 23, 2024 Aug 23, 2024
424B5 Prospectus supplement Aug 23, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Other events
Jul 29, 2024 Jul 29, 2024
8-K Current report
Officer or director change
Jul 18, 2024 Jul 17, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 12, 2024
8-K Current report
Officer or director change
May 31, 2024 May 24, 2024
8-K Current report
Other events
May 24, 2024 May 23, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 12, 2024
8-K Current report
Officer or director change
Mar 22, 2024 Mar 18, 2024
S-8 Employee stock plan registration Feb 23, 2024 —
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 22, 2024 Feb 22, 2024
8-K Current report
Officer or director change
Feb 1, 2024 Jan 26, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Material agreement, Other events
Dec 21, 2023 Dec 20, 2023
424B5 Prospectus supplement Dec 21, 2023 —
8-K Current report
Other events
Dec 19, 2023 Dec 19, 2023
8-K Current report
Other events
Nov 15, 2023 Nov 14, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
8-K Current report
Officer or director change
Nov 3, 2023 Nov 2, 2023
8-K Current report
Regulation FD disclosure
Sep 7, 2023 Sep 7, 2023
S-8 Employee stock plan registration Aug 10, 2023 —
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Other events
Aug 1, 2023 Aug 1, 2023
8-K Current report
Shareholder vote results
Jun 20, 2023 Jun 14, 2023
8-K Current report
Other events
May 25, 2023 May 22, 2023
424B5 Prospectus supplement May 24, 2023 —
424B5 Prospectus supplement May 22, 2023 —
S-3ASR Automatic shelf registration May 22, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Regulation FD disclosure
May 9, 2023 May 9, 2023
8-K Current report
Officer or director change
May 8, 2023 May 3, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 —
8-K Current report
Auditor change
Apr 10, 2023 Apr 4, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
S-8 Employee stock plan registration Mar 2, 2023 —
8-K Current report
Officer or director change
Feb 27, 2023 Feb 21, 2023
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Regulation FD disclosure
Dec 15, 2022 Dec 15, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Jul 7, 2022 Jun 30, 2022
8-K Current report
Shareholder vote results
Jun 21, 2022 Jun 15, 2022
8-K Current report
Agreement ended, Other events
Jun 13, 2022 Jun 10, 2022
DEFA14A Additional proxy material Jun 8, 2022 —
8-K Current report
Officer or director change
May 6, 2022 May 4, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 15, 2022
S-8 Employee stock plan registration Feb 28, 2022 —
8-K Current report
Officer or director change, Other events
Feb 28, 2022 Feb 28, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 23, 2022 Feb 23, 2022
CT ORDER Filing Feb 8, 2022 —
8-K Current report
Other events
Jan 7, 2022 Dec 31, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Officer or director change
Oct 20, 2021 Oct 15, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Officer or director change
Aug 5, 2021 Aug 4, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Shareholder vote results
Jun 21, 2021 Jun 21, 2021
8-K Current report
Other events
May 17, 2021 May 13, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 29, 2021 —
DEF 14A Proxy statement Apr 29, 2021 Jun 16, 2021
S-8 Employee stock plan registration Mar 1, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 24, 2021 Feb 24, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Material agreement
Jan 7, 2021 Jan 1, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 11, 2020 Dec 11, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 20, 2020 Nov 16, 2020
8-K Current report
Other events
Nov 17, 2020 Nov 16, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Other events
Oct 13, 2020 Oct 6, 2020
424B7 Filing Oct 8, 2020 —
424B7 Filing Oct 6, 2020 —
8-K/A Amended current report
Officer or director change
Oct 6, 2020 Feb 24, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Officer or director change
Jun 16, 2020 Jun 12, 2020
8-K Current report
Shareholder vote results
Jun 15, 2020 Jun 12, 2020

Showing 146 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
GH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
Large accelerated filer
SEC CIK
1576280

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.